Newsletter Desktop Newsletter Mobile

Ann Arbor-based MedKairos Inc., which does business as Pathware, has closed a $1.46 million investment round from undisclosed angel investors.

It is the first successful fundraising round for the company since a friends and family round in 2017. The company, a developer of a cancer diagnostic device that automates the biopsy process to aid in early-stage cancer detection, previously received a $50,000 grant from the National Science Foundation in 2016.

The company was part of the 2017 Life Sciences Aspire Cohort of VentureWell, a nonprofit that helps collegiate faculty and student innovators solve the world's biggest problems.